Results 61 to 70 of about 5,791,370 (216)

A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control

Microorganisms, 2021
Neisseria meningitidis, carried in the human nasopharynx asymptomatically by ~10% of the population, remains a leading cause of meningitis and rapidly fatal sepsis, usually in otherwise healthy individuals.
Yih-Ling Tzeng, David S. Stephens
doaj   +1 more source

Chemoenzymatic Synthesis of Well‐Defined α(2,8)‐ and α(2,9)‐Linked Oligosialosides

Angewandte Chemie, Volume 138, Issue 36, 1 September 2026.
Well‐defined α(2,8)‐ and α(2,9)‐linked oligosialic acids of different lengths can be prepared by employing recombinant bacterial polysialyltransferases in combination with chemically modified CMP‐Neu5Ac derivatives. After transfer, a sialoside is formed bearing an artificial entity, which blocks further glycosylation.
Jelle A. Fok, Keshav Kishor, Mehman I. Bunyatov, Gerlof P. Bosman, Geert‐Jan Boons   +4 more
wiley   +2 more sources

Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection

Canadian Journal of Infectious Diseases and Medical Microbiology, 2009
Canada is a leader in establishing routine infant immunization programs against meningococcal C disease. Currently, all provinces have routine programs to provide meningococcal C conjugate vaccines to infants and children.
Nicole Le Saux, Julie A Bettinger, Susan Wootton, Scott A Halperin, Wendy Vaudry, David W Scheifele, Raymond Tsang   +6 more
doaj   +1 more source

Insights on Population Structure and Within-Host Genetic Changes among Meningococcal Carriage Isolates from U.S. Universities

mSphere, 2020
In 2015 and 2016, meningococcal carriage evaluations were conducted at two universities in the United States following mass vaccination campaigns in response to Neisseria meningitidis serogroup B (NmB) disease outbreaks.
Sandeep J. Joseph, Nadav Topaz, How-Yi Chang, Melissa J. Whaley, Jeni T. Vuong, Alexander Chen, Fang Hu, Susanna E. Schmink, Laurel T. Jenkins, Lorraine D. Rodriguez-Rivera, Jennifer D. Thomas, Anna M. Acosta, Lucy McNamara, Heidi M. Soeters, Sarah Mbaeyi, Xin Wang   +15 more
doaj   +1 more source

Invasive Meningococcal Disease in Adolescents and Young Adults [PDF]

JAMA, 2001
Incidence of invasive meningococcal disease has increased recently in persons aged 15 through 24 years.To characterize meningococcal infection in adolescents and young adults in Maryland during the 1990s.Population-based surveillance study for meningococcal disease from January 1, 1990, through December 31, 1999, in Maryland.Maryland residents ...
L H, Harrison, M A, Pass, A B, Mendelsohn, M, Egri, N E, Rosenstein, A, Bustamante, J, Razeq, J C, Roche   +7 more
openaire   +2 more sources

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence [version 2; peer review: 2 approved]

Wellcome Open Research, 2019
Carriage of Neisseria meningitidis, the meningococcus, is a prerequisite for invasive meningococcal disease (IMD), a potentially devastating infection that disproportionately afflicts infants and children.
Holly B. Bratcher, Charlene M. C. Rodrigues, Adam Finn, Mandy Wootton, J. Claire Cameron, Andrew Smith, Paul Heath, Shamez Ladhani, Matthew D. Snape, Andrew J. Pollard, Richard Cunningham, Raymond Borrow, Caroline Trotter, Stephen J. Gray, Martin C. J. Maiden, Jenny M. MacLennan   +15 more
doaj   +1 more source

Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).

PLoS ONE, 2023
Invasive meningococcal disease belongs among the most dangerous infectious diseases in the world. Several polysaccharide conjugate vaccines against serogroups A, C, W and Y are available and two recombinant peptide vaccines against serogroup B (MenB ...
Michal Honskus, Pavla Krizova, Zuzana Okonji, Martin Musilek, Jana Kozakova   +4 more
doaj   +1 more source

Engineering Microbial Particles for Next‐Generation Biomedical Platforms

Advanced Science, EarlyView.
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li, Yunjie Lu, Ziyan Huang, Jianjiang Chen, Yanbin Liu, Lei Qin, Chao Wang, Yumin Wu   +7 more
wiley   +1 more source

Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009 [PDF]

, 2014
Neisseria meningitidis is a major cause of bacterial meningitis and a considerable health problem in the 25 countries of the 'African Meningitis Belt' that extends from Senegal in West Africa to Ethiopia in the East.
Calman MacLennan, Gerd Pluschke, Koeberling, Oliver, Oliver Koeberling, Ispasanie, Emma, MacLennan, Calman, Emma Ispasanie, Ali Sie, Abraham Hodgson, Pluschke, Gerd, Hodgson, Abraham, Sie, Ali, Pluschke G, MacLennan C, Ispasanie E, Sie A, Hodgson A, Koeberling O   +17 more
core   +1 more source

Vaccination for girls and women across the life course: Evidence‐based recommendations for clinical practice and policy

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Vaccination across the life course is a cornerstone of preventive health care for girls and women. Although WHO recommends completion of essential vaccines by adolescence, global coverage remains suboptimal. Vaccine‐preventable diseases—including HPV‐related cancers, vaginal, vulvar, anal, oropharyngeal, influenza, pertussis, hepatitis B ...
Hema Divakar, Fionnuala M. McAuliffe, Gelila Goba, Chiara Benedetto, Méabh N. Bhuinneáin, Suvarna Khadilkar, Marisa Labovsky, Michael Abou‐Dakn, Eytan R. Barnea, Agnaldo Lopes da Silva‐Filho, Elizabete Argale, Andrea Genazzani, Diana Ramos, Dharmintra Pasupathy   +13 more
wiley   +1 more source